NMRA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Offering Documents") issued in connection with Neumora's September 2023 initial public ...
NEW YORK, March 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Neumora Therapeutics, Inc. (NASDAQ: NMRA). Shareholders who purchased shares of NMRA ...
The Allegations: Robbins LLP is Investigating Allegations that Neumora Therapeutics, Inc. (NMRA) Misled Investors in the Offering Documents in Support of its IPO According to the complaint ...